Olaparib
id:
olaparib-184-11737832
title:
Olaparib
text:
Olaparib, sold under the brand name Lynparza, is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers. In December 2014, olaparib was approved for use as a single agent by the European Medicines Agency (EMA) in the Europea
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound (cancer therapy drug)
original url:
https://en.wikipedia.org/wiki/Olaparib
date created:
2009-06-25T04:54:09Z
date modified:
2024-09-07T11:10:38Z
main entity:
{"identifier":"Q7083106","url":"https://www.wikidata.org/entity/Q7083106"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/0/06/Olaparib.svg","width":512,"height":208}
fields total:
13
integrity:
16